A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

A new form of focal therapy for prostate cancer has made its way to the Natural State, set to be offered by the University of ...

SYNLAB Nigeria, a leader in medical diagnostics, is at the forefront of this critical process, ensuring that individuals and ...

This randomized, double-blind, placebo-controlled Phase III trial was designed to test the efficacy ... of-study biopsy if serum PSA levels fell within a prespecified range. Prostate cancer ...

Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Wednesday, April 16th, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...

A new business in Lower Paxton Township is looking to help treat men’s health issues. Gameday Men’s Health might sound like ...

Blood Analysis Program, co-sponsored by the Wood County Hospital Foundation and the Bowling Green Chamber of Commerce ...

Jaguar Health, Inc nnounced the results of a new survey of 27 board certified veterinary oncologists practicing in the U.S. regarding Canalevia-CA1 and the treatment of chemotherapy-induced ...

The saliva test appears to be more accurate than the standard test, which uses blood samples. View on euronews ...

Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.

Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic ...

The deal will see ReVolt’s “dual-power system” put to the test in real-world conditions, pairing its e-axles’ battery-electric torque with up to 1,200 miles of diesel-extended range.